Shi L - Search Results

1

Impact of Insulin Receptor Substrate-1 rs956115 and CYP2C19 rs4244285 Genotypes on Clinical Outcome of Patients Undergoing Percutaneous Coronary Intervention.

Zong J, Tang Y, Wang T, Ullah I, Xu K, Wang J, Chen P, Chen Z, Zhu T, Chen J, Li J, Wang F, Yang L, Fan Y, Shi L, Gong X, Eikelboom JW, Zhao Y, Li C. Zong J, et al. Among authors: shi l. J Am Heart Assoc. 2022 Aug 16;11(16):e025058. doi: 10.1161/JAHA.121.025058. Epub 2022 Aug 5. J Am Heart Assoc. 2022. PMID: 35929455 Free PMC article.

2

Serum uric acid level negatively correlated with the prevalence of clopidogrel low response in patients undergoing antiplatelet treatment with aspirin and clopidogrel.

Wang J, Abdus S, Tan C, Gu Q, Yang M, Wang G, Shi L, Gong X, Li C. Wang J, et al. Among authors: shi l. Nutr Metab Cardiovasc Dis. 2020 Nov 27;30(12):2215-2220. doi: 10.1016/j.numecd.2020.07.025. Epub 2020 Jul 24. Nutr Metab Cardiovasc Dis. 2020. PMID: 32912788

3

Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.

Yang M, Ye Z, Mei L, Ullah I, Tan C, Wang G, Gu Q, Lu Y, Abdus S, Shi L, Gong X, Bai J, Eikelboom JW, Li C. Yang M, et al. Among authors: shi l. Eur J Clin Pharmacol. 2021 Dec;77(12):1815-1823. doi: 10.1007/s00228-021-03177-y. Epub 2021 Jul 31. Eur J Clin Pharmacol. 2021. PMID: 34331551 Clinical Trial.

4

Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial.

Ying L, Wang J, Li J, Teng J, Zhang X, Ullah I, Samee A, Xu K, Chen J, Xu L, Zhu H, Li J, Yang L, Wang F, Fan Y, Zhang J, Lu Y, Gong X, Shi L, Eikelboom JW, Li C. Ying L, et al. Among authors: shi l. Br J Haematol. 2022 Jan;196(2):424-432. doi: 10.1111/bjh.17847. Epub 2021 Oct 5. Br J Haematol. 2022. PMID: 34611892 Clinical Trial.

5

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention.

Wang J, Wang J, Dong Z, Ma J, Teng J, Wang T, Zhang X, Gu Q, Ye Z, Ullah I, Tan C, Abdus S, Shi L, Gong X, Li C. Wang J, et al. Among authors: shi l. Thromb J. 2021 Oct 19;19(1):73. doi: 10.1186/s12959-021-00323-5. Thromb J. 2021. PMID: 34666778 Free PMC article.

6

Simultaneous determination of clopidogrel, 2-oxo-clopidogrel, and the thiol metabolite of clopidogrel in human plasma by LC-MS/MS.

Xu L, Li R, Li J, Dong Z, Zong J, Tan C, Ye Z, Shi L, Gong X, Li C. Xu L, et al. Among authors: shi l. J Biomed Res. 2022 Feb 28;36(2):109-119. doi: 10.7555/JBR.36.20210125. J Biomed Res. 2022. PMID: 35387902 Free PMC article.

7

Efficacy of an adjusted treatment strategy on the management and in-hospital outcome of patients with STEMI during the COVID-19 pandemic.

Wang J, Ullah I, Dong Z, Ye Z, Gu Q, Tan C, Ma J, Teng J, Shi L, Gong X, Li Y, Yuan L, Xu Z, Li C. Wang J, et al. Among authors: shi l. J Biomed Res. 2022 Jan 12;36(1):70-72. doi: 10.7555/JBR.35.20210173. J Biomed Res. 2022. PMID: 35403614 Free PMC article. No abstract available.

8

Effect of statins combined with PCSK9 inhibitors on the prognosis of patients with acute coronary syndromes after interventional therapy.

Shi L, Ye Z, Gu Q, Li Y. Shi L, et al. Cell Mol Biol (Noisy-le-grand). 2023 Nov 30;69(12):262-267. doi: 10.14715/cmb/2023.69.12.41. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 38063128

9

The Impact of a Multifaceted Pharmacist-Led Antimicrobial Stewardship Program on Antibiotic Use: Evidence From a Quasi-Experimental Study in the Department of Vascular and Interventional Radiology in a Chinese Tertiary Hospital.

Xu J, Huang J, Yu Y, Zhou D, Wang Y, Xue S, Shang E, Sun J, Ding X, Shi L, Duan L, Tang L, Zhou Q, Li X. Xu J, et al. Among authors: shi l. Front Pharmacol. 2022 Feb 28;13:832078. doi: 10.3389/fphar.2022.832078. eCollection 2022. Front Pharmacol. 2022. PMID: 35295325 Free PMC article.

10

Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study.

Lu H, Duan L, Yu Y, Li J, Shi L, Xue S, Zhang Q, Zhou Q, Zhu C, Shang E, Yan X, Tang L. Lu H, et al. Among authors: shi l. J Chemother. 2022 Nov;34(7):446-458. doi: 10.1080/1120009X.2022.2086305. Epub 2022 Jun 30. J Chemother. 2022. PMID: 35773225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,270 results

Search Page